Release Date: 21/12/10 15:41 Summary: Notice to Call Extraordinary General Meeting Price Sensitive: No Download Document 11.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%